Palisade Bio Inc. buy Brookline Capital Management
Start price
20.11.24
/
50%
€0.34
Target price
20.11.25
€36.03
Performance (%)
-
End price
21.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Palisade Bio Inc. | - | - | - |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Trading Palisade Bio Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten
In the thread Palisade Bio Inc. diskutieren
Palisade Bio, Inc. (NASDAQ: PALI) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $38.00 price target on the stock.
Ratings data for PALI provided by MarketBeat